So far, in vivo and in vitro studies indicated that Lgals3/galectin-3 plays critical roles in several ocular diseases, e.g., dry eye, glaucoma, uveitis, and diabetic retinopathy [21,22,23]. Here, LGALS3 is linked to Keratoconjunctivitis sicca.